<DOC>
	<DOCNO>NCT01210365</DOCNO>
	<brief_summary>The study consist two treatment group , one group receive Diurisa® ( furosemide 40 mg + amiloride chloride 10 mg ) one receive furosemide 40 mg ( Lasix® )</brief_summary>
	<brief_title>Safety Efficacy Furosemide 40mg + Amiloride Hydrochloride 10mg Reduct Edema</brief_title>
	<detailed_description>General Purpose 1 . To comparatively evaluate tolerability efficacy fix combination furosemide ( 40 mg ) amiloride ( 10 mg ) compare furosemide alone , treatment patient HF functional class II ( NYHA ) Specific Purposes 1 . To evaluate effect kalemia fix combination furosemide amiloride compare furosemide alone treatment patient HF functional class II ( NYHA ) 2 . To evaluate efficacy fix combination furosemide amiloride reduce edema LLLL , compare furosemide alone , treatment patient HF functional class II ( NYHA ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Amiloride</mesh_term>
	<criteria>1 . Being 18 year old 2 . Must able follow instruction attend study visit . 3 . Diagnosis CHF functional class II ( NYHA ) without prior use diuretic 4 . Women childbearing potential use reliable contraceptive method , assess principal investigator 1 . Any clinically significant , serious severe medical condition ( e.g. , Thyroid , renal liver disorder , Chronic Obstructive Pulmonary Disease , etc . ) 2 . History acute myocardial infarction ( within 6 month ) decompensated coronary artery disease 3 . Pulmonary hypertension PASP &gt; 45 mmHg 4 . Fasting blood glucose 150 mg/dl 5 . Psychiatric neurological disorder 6 . A condition , accord Principal Investigator 's opinion , may interfere optimal study participation may put patient special risk . 7 . Participation investigational study within 12 month sign ICF . 8 . Known medical history allergy , hypersensitivity intolerance component drug use study . 9 . Any medical treatment unrelated study schedule clinical trial period , except nonserious wellcontrolled comorbidities already follow medically . 10 . Another drug schedule initiate study entry . 11 . Obesity BMI &gt; 30 kg/m2 12 . Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>CHF functional class II</keyword>
	<keyword>Patients CHF</keyword>
	<keyword>Patients CHF functional class II ( NYHA ) etiology</keyword>
</DOC>